These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 22733221)

  • 1. Inflammatory and non-inflammatory breast cancer survival by socioeconomic position in the Surveillance, Epidemiology, and End Results database, 1990-2008.
    Schlichting JA; Soliman AS; Schairer C; Schottenfeld D; Merajver SD
    Breast Cancer Res Treat; 2012 Aug; 134(3):1257-68. PubMed ID: 22733221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of inflammatory and noninflammatory breast cancer with socioeconomic characteristics in the Surveillance, Epidemiology, and End Results database, 2000-2007.
    Schlichting JA; Soliman AS; Schairer C; Banerjee M; Rozek LS; Schottenfeld D; Harford JB; Merajver SD
    Cancer Epidemiol Biomarkers Prev; 2012 Jan; 21(1):155-65. PubMed ID: 22028401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial/ethnic differences in breast cancer survival by inflammatory status and hormonal receptor status: an analysis of the Surveillance, Epidemiology, and End Results data.
    Schinkel JK; Zahm SH; Jatoi I; McGlynn KA; Gallagher C; Schairer C; Shriver CD; Zhu K
    Cancer Causes Control; 2014 Aug; 25(8):959-68. PubMed ID: 24839049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of survival in non-metastatic inflammatory and other T4 breast cancers: a SEER population-based analysis.
    Jiao D; Zhang J; Zhu J; Guo X; Yang Y; Xiao H; Liu Z
    BMC Cancer; 2021 Feb; 21(1):138. PubMed ID: 33549037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial disparities in treatment and outcomes between non-Hispanic Black and non-Hispanic White women with nonmetastatic inflammatory breast cancer.
    Carbajal-Ochoa WH; Johnson D; Alvarez A; Bernal AM; Anampa JD
    Breast Cancer Res Treat; 2023 Sep; 201(2):275-287. PubMed ID: 37442877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in survival among women with stage III inflammatory and noninflammatory locally advanced breast cancer appear early: a large population-based study.
    Dawood S; Ueno NT; Valero V; Woodward WA; Buchholz TA; Hortobagyi GN; Gonzalez-Angulo AM; Cristofanilli M
    Cancer; 2011 May; 117(9):1819-26. PubMed ID: 21509759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying factors that impact survival among women with inflammatory breast cancer.
    Dawood S; Ueno NT; Valero V; Woodward WA; Buchholz TA; Hortobagyi GN; Gonzalez-Angulo AM; Cristofanilli M
    Ann Oncol; 2012 Apr; 23(4):870-5. PubMed ID: 21765048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marital status is an independent prognostic factor in inflammatory breast cancer patients: an analysis of the surveillance, epidemiology, and end results database.
    Liu YL; Wang DW; Yang ZC; Ma R; Li Z; Suo W; Zhao Z; Li ZW
    Breast Cancer Res Treat; 2019 Nov; 178(2):379-388. PubMed ID: 31414242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute.
    Hance KW; Anderson WF; Devesa SS; Young HA; Levine PH
    J Natl Cancer Inst; 2005 Jul; 97(13):966-75. PubMed ID: 15998949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overall survival differences between patients with inflammatory and noninflammatory breast cancer presenting with distant metastasis at diagnosis.
    Fouad TM; Kogawa T; Liu DD; Shen Y; Masuda H; El-Zein R; Woodward WA; Chavez-MacGregor M; Alvarez RH; Arun B; Lucci A; Krishnamurthy S; Babiera G; Buchholz TA; Valero V; Ueno NT
    Breast Cancer Res Treat; 2015 Jul; 152(2):407-16. PubMed ID: 26017070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival of women with inflammatory breast cancer: a large population-based study.
    Dawood S; Lei X; Dent R; Gupta S; Sirohi B; Cortes J; Cristofanilli M; Buchholz T; Gonzalez-Angulo AM
    Ann Oncol; 2014 Jun; 25(6):1143-51. PubMed ID: 24669011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial/ethnic disparities in inflammatory breast cancer survival in the Michigan Cancer Surveillance Program.
    Gudina AT; Copeland G; Soliman AS; Hirko KA
    Breast Cancer Res Treat; 2019 Feb; 173(3):693-699. PubMed ID: 30406365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction and Validation of Nomograms for Predicting Overall Survival and Cancer-Specific Survival in Nonmetastatic Inflammatory Breast Cancer Patients Receiving Tri-Modality Therapy: A Population-Based Study.
    Huang Q; Xu TY; Wu ZY
    Med Sci Monit; 2019 Dec; 25():9167-9178. PubMed ID: 31789307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program of the National Cancer Institute, 1975-1992.
    Chang S; Parker SL; Pham T; Buzdar AU; Hursting SD
    Cancer; 1998 Jun; 82(12):2366-72. PubMed ID: 9635529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistent socioeconomic inequalities in cancer survival in the United States: 1973-2007 surveillance, epidemiology and end results (SEER) data for breast cancer and non-Hodgkin's lymphoma.
    Kato I; Booza J; Quarshie WO; Schwartz K
    J Registry Manag; 2012; 39(4):158-66. PubMed ID: 23493021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: National Longitudinal Mortality Study.
    Clegg LX; Reichman ME; Miller BA; Hankey BF; Singh GK; Lin YD; Goodman MT; Lynch CF; Schwartz SM; Chen VW; Bernstein L; Gomez SL; Graff JJ; Lin CC; Johnson NJ; Edwards BK
    Cancer Causes Control; 2009 May; 20(4):417-35. PubMed ID: 19002764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What can we learn from the age- and race/ethnicity- specific rates of inflammatory breast carcinoma?
    Il'yasova D; Siamakpour-Reihani S; Akushevich I; Akushevich L; Spector N; Schildkraut J
    Breast Cancer Res Treat; 2011 Nov; 130(2):691-7. PubMed ID: 21850396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic impact of human epidermal growth factor-like receptor 2 and hormone receptor status in inflammatory breast cancer (IBC): analysis of 2,014 IBC patient cases from the California Cancer Registry.
    Zell JA; Tsang WY; Taylor TH; Mehta RS; Anton-Culver H
    Breast Cancer Res; 2009; 11(1):R9. PubMed ID: 19228416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of patients with inflammatory breast cancer by hormone receptor- and HER2-defined molecular subtypes: A population-based study from the SEER program.
    Li J; Xia Y; Wu Q; Zhu S; Chen C; Yang W; Wei W; Sun S
    Oncotarget; 2017 Jul; 8(30):49370-49379. PubMed ID: 28472761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Socioeconomic status and breast carcinoma survival in four racial/ethnic groups: a population-based study.
    O'Malley CD; Le GM; Glaser SL; Shema SJ; West DW
    Cancer; 2003 Mar; 97(5):1303-11. PubMed ID: 12599239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.